Risk factors in the spread of leishmaniases: Towards integrated monitoring?

Trends in Parasitology

Volumn 22, Issue 1, 2006, Pages 4-6

  Dujardin, Jean Claude ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ENVIRONMENTAL FACTOR; HEALTH SURVEY; HUMAN; IMMUNE STATUS; INFECTION CONTROL; LEISHMANIASIS; MONITORING; NONHUMAN; PARASITE TRANSMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT FAILURE;

EID: 29544439384     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2005.11.004     Document Type: Short Survey

References (13)

1. S. Croft, and G. Coombs Leishmaniasis, current chemotherapy and recent advances in the search for novel drugs Trends Parasitol. 19 2003 502 508
2. P. Desjeux The increase in risk factors for leishmaniasis worldwide Trans. R. Soc. Trop. Med. Hyg. 95 2001 239 243
3. A.T. Peterson, and J. Shaw Lutzomyia vectors for cutaneous leishmaniasis in Southern Brazil: ecological niche models, predicted geographic distributions, and climate change effects Int. J. Parasitol. 33 2003 919 931
4. R. Reithinger Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan Emerg. Infect. Dis. 9 2003 727 729
5. E.E. Zijlstra, and A.M. el-Hassan Leishmaniasis in Sudan. Visceral leishmaniasis Trans. R. Soc. Trop. Med. Hyg. 95 Suppl. 1 2001 S27 S58
6. R. Lopez-Velez The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are coinfected with HIV Ann. Trop. Med. Parasitol. 97 Suppl. 1 2003 143 147
7. J. Alvar, and M. Jimenez Could infected drug-users be potential Leishmania infantum reservoirs? AIDS 8 1994 854
8. K. Ritmeijer Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome Trans. R. Soc. Trop. Med. Hyg. 95 2001 668 672
9. M.L. Fernandez-Guerrero Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis Acta Trop. 90 2004 11 16
10. S. Sundar Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic Clin. Infect. Dis. 31 2000 1104 1107
11. H. Sindermann Miltefosine (Impavido): the first oral treatment against leishmaniasis Med. Microbiol. Immunol. (Berl.) 193 2004 173 180
12. F.J. Perez-Victoria Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug Antimicrob. Agents Chemother. 47 2003 2397 2403
13. P. Desjeux, and J. Alvar Leishmania/HIV co-infections: epidemiology in Europe Ann. Trop. Med. Parasitol. 97 Suppl. 1 2003 3 15